Literature DB >> 26400205

Modulating of ocular inflammation with macrophage migration inhibitory factor is associated with notch signalling in experimental autoimmune uveitis.

H Yang1, S Zheng1, Y Mao2, Z Chen1, C Zheng1, H Li2, C Sumners3, Q Li4, P Yang1, B Lei1.   

Abstract

The aim of this study was to examine whether macrophage migration inhibitory factor (MIF) could exaggerate inflammatory response in a mouse model of experimental autoimmune uveitis (EAU) and to explore the underlying mechanism. Mutant serotype 8 adeno-associated virus (AAV8) (Y733F)-chicken β-actin (CBA)-MIF or AAV8 (Y733F)-CBA-enhanced green fluorescent protein (eGFP) vector was delivered subretinally into B10.RIII mice, respectively. Three weeks after vector delivery, EAU was induced with a subcutaneous injection of a mixture of interphotoreceptor retinoid binding protein (IRBP) peptide with CFA. The levels of proinflammatory cytokines were detected by real-time polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA). Retinal function was evaluated with electroretinography (ERG). We found that the expression of MIF and its two receptors CD74 and CD44 was increased in the EAU mouse retina. Compared to AAV8.CBA.eGFP-injected and untreated EAU mice, the level of proinflammatory cytokines, the expression of Notch1, Notch4, delta-like ligand 4 (Dll4), Notch receptor intracellular domain (NICD) and hairy enhancer of split-1 (Hes-1) increased, but the ERG a- and b-wave amplitudes decreased in AAV8.CBA.MIF-injected EAU mice. The Notch inhibitor N-[N-(3,5-difluorophenacetyl)-l-alanyl]-S-phenylglycine t-butyl ester (DAPT) reduced the expression of NICD, Hes-1 and proinflammatory cytokines. Further, a MIF antagonist ISO-1 attenuated intraocular inflammation, and inhibited the differentiation of T helper type 1 (Th1) and Th17 in EAU mice. We demonstrated that over-expression of MIF exaggerated ocular inflammation, which was associated with the activation of the Notch signalling. The expression of both MIF and its receptors are elevated in EAU mice. Over-expression of MIF exaggerates ocular inflammation, and this exaggerated inflammation is associated with the activation of the Notch signalling and Notch pathway. Our data suggest that the MIF-Notch axis may play an important role in the pathogenesis of EAU. Both the MIF signalling pathways may be promising targets for developing novel therapeutic interventions for uveitis.
© 2015 British Society for Immunology.

Entities:  

Keywords:  EAU; MIF; Notch; inflammation; retina

Mesh:

Substances:

Year:  2015        PMID: 26400205      PMCID: PMC4711161          DOI: 10.1111/cei.12710

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  54 in total

1.  Inhibition of experimental autoimmune uveoretinitis with anti-macrophage migration inhibitory factor antibodies.

Authors:  N Kitaichi; A Matsuda; S Kotake; K Namba; Y Tagawa; Y Sasamoto; K Ogasawara; K Iwabuchi; K Onoé; H Matsuda; J Nishihira
Journal:  Curr Eye Res       Date:  2000-02       Impact factor: 2.424

2.  MIF regulates innate immune responses through modulation of Toll-like receptor 4.

Authors:  T Roger; J David; M P Glauser; T Calandra
Journal:  Nature       Date:  2001 Dec 20-27       Impact factor: 49.962

Review 3.  Macrophage migration inhibitory factor.

Authors:  John A Baugh; Richard Bucala
Journal:  Crit Care Med       Date:  2002-01       Impact factor: 7.598

4.  The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents.

Authors:  Jodi B Lubetsky; Angeles Dios; Jialian Han; Bayan Aljabari; Bela Ruzsicska; Robert Mitchell; Elias Lolis; Yousef Al-Abed
Journal:  J Biol Chem       Date:  2002-05-07       Impact factor: 5.157

5.  In vivo blockade of macrophage migration inhibitory factor ameliorates acute experimental autoimmune encephalomyelitis by impairing the homing of encephalitogenic T cells to the central nervous system.

Authors:  Claudia M Denkinger; Michael Denkinger; Jens J Kort; Christine Metz; Thomas G Forsthuber
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

6.  Delta1-Notch3 interactions bias the functional differentiation of activated CD4+ T cells.

Authors:  Yoichi Maekawa; Shin-ichi Tsukumo; Shigeru Chiba; Hisamaru Hirai; Yuki Hayashi; Hiroko Okada; Kenji Kishihara; Koji Yasutomo
Journal:  Immunity       Date:  2003-10       Impact factor: 31.745

Review 7.  Macrophage migration inhibitory factor in uveitis.

Authors:  Satoshi Kotake; Nobuyoshi Kitaichi; Shigeaki Ohno
Journal:  Int Ophthalmol Clin       Date:  2002

8.  Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor.

Authors:  Derek Lacey; Annaleise Sampey; Robert Mitchell; Richard Bucala; Lanie Santos; Michelle Leech; Eric Morand
Journal:  Arthritis Rheum       Date:  2003-01

Review 9.  MIF, CD74 and other partners in kidney disease: tales of a promiscuous couple.

Authors:  M D Sanchez-Niño; A B Sanz; O Ruiz-Andres; J Poveda; M C Izquierdo; R Selgas; J Egido; A Ortiz
Journal:  Cytokine Growth Factor Rev       Date:  2012-09-07       Impact factor: 7.638

Review 10.  Macrophage migration inhibitory factor: a regulator of innate immunity.

Authors:  Thierry Calandra; Thierry Roger
Journal:  Nat Rev Immunol       Date:  2003-10       Impact factor: 53.106

View more
  5 in total

Review 1.  Deep Insight into the Role of MIF in Spondyloarthritis.

Authors:  Brian Wu; Akihiro Nakamura
Journal:  Curr Rheumatol Rep       Date:  2022-07-09       Impact factor: 4.686

Review 2.  Targeting the Notch Signaling Pathway in Chronic Inflammatory Diseases.

Authors:  Panagiotis F Christopoulos; Torleif T Gjølberg; Stig Krüger; Guttorm Haraldsen; Jan Terje Andersen; Eirik Sundlisæter
Journal:  Front Immunol       Date:  2021-04-12       Impact factor: 7.561

3.  Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression.

Authors:  Tyler J Alban; Defne Bayik; Balint Otvos; Anja Rabljenovic; Lin Leng; Leu Jia-Shiun; Gustavo Roversi; Adam Lauko; Arbaz A Momin; Alireza M Mohammadi; David M Peereboom; Manmeet S Ahluwalia; Kazuko Matsuda; Kyuson Yun; Richard Bucala; Michael A Vogelbaum; Justin D Lathia
Journal:  Front Immunol       Date:  2020-06-18       Impact factor: 7.561

4.  Inhibition of Macrophage Migration Inhibitory Factor Protects against Inflammation through a Toll-like Receptor-Related Pathway after Diffuse Axonal Injury in Rats.

Authors:  Yonglin Zhao; Xing Wei; Weimiao Li; Changyou Shan; Jinning Song; Ming Zhang
Journal:  Biomed Res Int       Date:  2020-09-05       Impact factor: 3.411

5.  Identification of a novel genetic locus associated with immune-mediated thrombotic thrombocytopenic purpura.

Authors:  Matthew J Stubbs; Paul Coppo; Chris Cheshire; Agnès Veyradier; Stephanie Dufek; Adam P Levine; Mari Thomas; Vaksha Patel; John O Connolly; Michael Hubank; Ygal Benhamou; Lionel Galicier; Pascale Poullin; Robert Kleta; Daniel P Gale; Horia Stanescu; Marie A Scully
Journal:  Haematologica       Date:  2022-03-01       Impact factor: 9.941

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.